Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6099943 | Journal of Crohn's and Colitis | 2013 | 5 Pages |
Abstract
In patients with inflammatory bowel disease receiving infliximab scheduled maintenance therapy, 1-hour infusion time for 10Â mg/kg infliximab appears to be well tolerated. Large prospective studies are needed to confirm our findings.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Abdenour Babouri, Anthony Buisson, Marc-André Bigard, Laurent Peyrin-Biroulet,